148 related articles for article (PubMed ID: 12587350)
1. [From neuroleptics to antipsychotics: the cognitive and emotional impact].
Blin O; Fakra E; Tardieu S; Micallef J
Encephale; 2002; 28 Spec No 2 Pt 2():S16-8. PubMed ID: 12587350
[No Abstract] [Full Text] [Related]
2. Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study.
Fakra E; Salgado-Pineda P; Besnier N; Azorin JM; Blin O
World J Biol Psychiatry; 2009; 10(4 Pt 3):719-28. PubMed ID: 17853271
[TBL] [Abstract][Full Text] [Related]
3. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.
Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363
[TBL] [Abstract][Full Text] [Related]
4. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.
Rémillard S; Pourcher E; Cohen H
Schizophr Res; 2005 Dec; 80(1):99-106. PubMed ID: 16162401
[TBL] [Abstract][Full Text] [Related]
5. Focus on risperidone.
Green B
Curr Med Res Opin; 2000; 16(2):57-65. PubMed ID: 10893649
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.
Addington J; Addington D
Can J Psychiatry; 1997 Nov; 42(9):983. PubMed ID: 9429073
[No Abstract] [Full Text] [Related]
8. Cerebral cortical gray expansion associated with two second-generation antipsychotics.
Garver DL; Holcomb JA; Christensen JD
Biol Psychiatry; 2005 Jul; 58(1):62-6. PubMed ID: 15992524
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
[TBL] [Abstract][Full Text] [Related]
10. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
Pajonk FG
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
[TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
Sharma T
Br J Psychiatry Suppl; 1999; (38):44-51. PubMed ID: 10884899
[No Abstract] [Full Text] [Related]
12. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
[TBL] [Abstract][Full Text] [Related]
13. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.
Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1101-7. PubMed ID: 17475386
[TBL] [Abstract][Full Text] [Related]
14. [Factors connected with the effect of risperidone on psychopathological symptoms and working memory in schizophrenia].
Borkowska A; Rybakowski J
Psychiatr Pol; 2002; 36(6 Suppl):225-33. PubMed ID: 12647443
[TBL] [Abstract][Full Text] [Related]
15. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.
Weiss E; Kemmler G; Fleischhacker WW
Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210
[No Abstract] [Full Text] [Related]
16. [Cognitive dysfunction in schizophrenia--new therapeutic possibilities. 11th ECNP. 31 October-4 November 1998, Paris].
Fortschr Neurol Psychiatr; 1998 Dec; 66(12 Suppl):1-4. PubMed ID: 9926343
[No Abstract] [Full Text] [Related]
17. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
Casademont J; Garrabou G; Miró O; López S; Pons A; Bernardo M; Cardellach F
J Clin Psychopharmacol; 2007 Jun; 27(3):284-8. PubMed ID: 17502776
[TBL] [Abstract][Full Text] [Related]
18. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
19. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
